Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>2Q26 revenue growth of 35% continues to validate pivot to a clinic-centric model. </li><li>Total revenue rose to $5.2M from $3.8M, with service revenue nearly doubling to $3.8M and now representing 74% of the top line.</li><li>Sleep testing contributed $2.4M, while the treatment centers contributed $0.8M versus nil a year ago, evidence that Vivos is capturing treatment economics that previously left the system. </li></ul>

2Q26 revenue growth of 35% continues to validate pivot to a clinic-centric model. Total revenue rose to $5.2M from $3.8M, with service revenue nearly doubling to $3.8M and now representing 74% of the top line.Sleep testing contributed $2.4M, while the treatment centers contributed $0.8M versus nil a year ago, evidence that Vivos is capturing treatment economics that previously left the system. 

VVOS: Clinic-Centric Pivot Gains Traction; Balance Sheet Remains the Key Catalyst

Vivos Therapeutics

VVOS: Clinic-Centric Pivot Gains Traction; Balance Sheet Remains the Key Catalyst